Cargando…
The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease
Sickle cell disease (SCD) is an extremely heterogeneous disease that has been associated with global morbidity and early mortality. More effective and inexpensive therapies are needed. During the last five years, the landscape of the pharmacotherapy of SCD has changed dramatically. Currently, 54 dru...
Autor principal: | Ballas, Samir K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951351/ https://www.ncbi.nlm.nih.gov/pubmed/31934320 http://dx.doi.org/10.4084/MJHID.2020.010 |
Ejemplares similares
-
Sickle Cell Anaemia: Progress in Pathogenesis and Treatment
por: Ballas, Samir K.
Publicado: (2012) -
Morphine for the Treatment of Pain in Sickle Cell Disease
por: Gupta, Mihir, et al.
Publicado: (2015) -
Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic
por: Ballas, Samir K.
Publicado: (2021) -
From Individualized Treatment of Sickle Cell Pain to Precision Medicine: A 40-Year Journey
por: Ballas, Samir K.
Publicado: (2016) -
Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm
por: Loudon, Brodie L, et al.
Publicado: (2016)